Explore

Rapid Read Rapid Read
Brazilian HIV Advocates Foresee USAID Funding Cuts, Stress Need for Health System Independence

Brazilian HIV Advocates Foresee USAID Funding Cuts, Stress Need for Health System Independence

At the Aids 2026 conference, Brazilian HIV advocates expressed that they had anticipated the reduction in USAID funding for HIV programs. Juliana Cesar, a political liaison coordinator at the Brazilian NGO Gestos, highlighted that Brazil's health system operates independently from foreign aid, allowing it to maintain robust HIV prevention and treatment programs. This independence has enabled Brazil to achieve significant milestones, such as eliminating HIV transmission to newborns. However, the reduction in foreign aid poses challenges, particularly in accessing the latest HIV treatments due to ongoing negotiations with pharmaceutical companies.
Rapid Read Rapid Read
Brazil's HIV Advocates Foresee USAID Funding Cuts, Emphasizing Self-Reliance

Brazil's HIV Advocates Foresee USAID Funding Cuts, Emphasizing Self-Reliance

Brazil's HIV advocates have long anticipated a reduction in USAID funding, a development they have been preparing for by ensuring the country's health system operates independently of foreign aid. Brazil's Unified Health System, which has been robust enough to eliminate HIV transmission to newborns by 2025, is a testament to this independence. However, challenges remain, such as limited access to the latest HIV preventions and treatments due to ongoing negotiations with pharmaceutical companies. The right to healthcare, enshrined in Brazil's constitution since 1988, has been pivotal in integrating HIV prevention and treatment into the national health agenda. Advocates like Juliana Cesar from the NGO Gestos have been vocal about the need for financial independence, encouraging other nations to adopt similar measures, such as Brazil's Financial Transaction Tax, which funded public health initiatives. Despite these efforts, the tax is being phased out as Brazil shifts politically to the right.
Rapid Read Rapid Read
Gilead's HIV Drug Lenacapavir Faces Pricing Challenges in Latin America

Gilead's HIV Drug Lenacapavir Faces Pricing Challenges in Latin America

Gilead Sciences has developed a new HIV drug, lenacapavir, which is nearly 100% effective in preventing HIV infection with just two shots a year. Despite its potential to significantly reduce HIV transmission, the drug's high cost poses a barrier to access in Latin American countries where it was tested. While Gilead has agreed to license generic versions of the drug at a reduced price in 120 low- and middle-income countries, many Latin American nations, classified as upper-middle-income, do not qualify for these discounts. This has led to protests and criticism at the International AIDS Society Conference in Rio De Janeiro, where activists and officials from countries like Brazil have expressed frustration over stalled negotiations with Gilead. The company is accused of demanding prices significantly higher than those offered to other countries with similar economic statuses.
Rapid Read Rapid Read
USAID Funding Cuts Threaten Global Access to New HIV Prevention Drug

USAID Funding Cuts Threaten Global Access to New HIV Prevention Drug

At the Aids 2026 Conference in Rio de Janeiro, experts highlighted the potential of lenacapavir, an injectable HIV prevention drug, to significantly reduce new HIV cases globally. The World Health Organization (WHO) has recommended prioritizing the expansion of lenacapavir access due to its effectiveness and the convenience of requiring only two injections annually. However, the dissolution of USAID, which previously provided a substantial portion of global HIV prevention funding, has led to a dramatic decline in investment. This reduction in funding is impacting the availability of the drug and the ability of organizations to reach those in need, particularly in regions facing poverty, stigma, or geographical barriers.
Rapid Read Rapid Read
Gilead Faces Pricing Controversy Over HIV Drug Lenacapavir in Latin America

Gilead Faces Pricing Controversy Over HIV Drug Lenacapavir in Latin America

Gilead Sciences is facing criticism over the pricing of its HIV prevention drug, lenacapavir, in Latin America. Despite the drug's potential to significantly reduce HIV infections, its high cost in countries like Brazil, Mexico, Argentina, and Peru has sparked protests. These countries, classified as 'upper-middle income,' do not qualify for the reduced price offered to lower-income nations. Activists and officials argue that the pricing strategy is unjust, given the drug's life-saving potential. Brazil's health minister has criticized Gilead for demanding prices significantly higher than those in other countries with similar economic status.
Rapid Read Rapid Read
WHO Criticizes Ultra-Processed Food Companies for Hindering Health Initiatives

WHO Criticizes Ultra-Processed Food Companies for Hindering Health Initiatives

The World Health Organization (WHO) has accused major ultra-processed food corporations of obstructing global efforts to combat the obesity crisis by suing governments that implement health measures. WHO Director General Tedros Adhanom Ghebreyesus highlighted that these lawsuits delay vital public health policies, costing countries billions in healthcare and legal expenses. The investigation found that companies like Coca-Cola, PepsiCo, and Kellogg's have filed numerous lawsuits against health policies in countries such as the US, UK, and Brazil. Despite public claims of supporting healthier diets, these companies are actively working to overturn or weaken regulations aimed at reducing junk food consumption.
Rapid Read Rapid Read
DR Congo Ebola Epidemic Becomes World's Second Largest Outbreak

DR Congo Ebola Epidemic Becomes World's Second Largest Outbreak

The Ebola epidemic in the Democratic Republic of the Congo (DRC) has become the world's second largest outbreak, with over 3,500 confirmed cases. The outbreak, caused by the Bundibugyo strain of the virus, has resulted in 1,556 deaths, with a case fatality rate of 44.1 percent. The rapid spread of the virus has prompted calls for increased global attention and resources to contain the epidemic.
Rapid Read Rapid Read
Amazon Rainforest's Moisture Pump Critical for South American Agriculture

Amazon Rainforest's Moisture Pump Critical for South American Agriculture

The Amazon rainforest plays a crucial role in generating moisture that forms invisible rivers in the sky, which travel thousands of kilometers to water farmland in Brazil, Bolivia, Peru, and Argentina. This phenomenon, known as 'flying rivers,' is essential for maintaining the agricultural productivity of these regions. According to Dr. Antonio Nobre, a leading scientific proponent of the flying rivers concept, the Amazon's moisture stream significantly contributes to the annual rainfall in major agricultural regions across the southern half of South America. If the Amazon rainforest ceased to function as a moisture pump, Brazil’s agricultural heartland, which produces about seventy percent of the country’s economic output, would become substantially drier over the next few years. Northern Bolivia and southern Peru would lose more than seventy percent of their annual precipitation, while northern Argentina and Paraguay could face desertification.
Rapid Read Rapid Read
US Apologises for Displaying Incorrect Africa Map at AIDS Conference

US Apologises for Displaying Incorrect Africa Map at AIDS Conference

The US State Department has apologized for displaying an incorrect map of Africa during an AIDS conference in Brazil. The map inaccurately located six African countries, including Nigeria and Mozambique. The error was revealed by conference participants and reported by Reuters. The State Department attributed the mistake to a last-minute modification of the slideshow. Despite the error, the US highlighted constructive discussions at the conference, which focused on global health assistance amid reduced US aid budgets.
Rapid Read Rapid Read
Bush Institute Releases Recommendations for America's Global Health Strategy

Bush Institute Releases Recommendations for America's Global Health Strategy

The George W. Bush Institute, in collaboration with ten global health organizations, has released a set of recommendations aimed at advancing the America First Global Health Strategy. These recommendations emphasize the importance of protecting progress in global health initiatives and ensuring that communities are not left behind. The strategy focuses on country ownership, reliable financing, and community engagement to sustain and build upon past successes. The Bush Institute also highlights personal stories, such as that of Elina Mwasinga from Malawi, to illustrate the transformative impact of U.S. global health programs like PEPFAR.
Reuters Reuters
Lula's payroll loans boom, but Brazilian defaults spike too

Lula's payroll loans boom, but Brazilian defaults spike too

By Marcela Ayres BRASILIA, July 30 (Reuters) - Brazil's payroll-deductible lending program for private-sector workers, part of President Luiz Inacio Lula da Silva's push to expand access to cheaper credit, grew explosively in the first half of the year while also boosting consumer delinquencies.
ARTnews ARTnews
Aerial Surveys of Brazil Find New Evidence of Pre-Colombian Civilization

Aerial Surveys of Brazil Find New Evidence of Pre-Colombian Civilization

The surveys turned up evidence of hundreds of earthworks not previously idenitified.